Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tailor Bio
Oakham, England, United Kingdomtailor.bio ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Tailor Bio develops an AI-driven precision oncology platform to identify patterns in tumour DNA associated with chromosomal instability. Their technology aims to predict patient response to cancer drugs, with a current focus on pan-cancer applications and a validated diagnostic test for ovarian cancer. The company has received Innovate UK funding and collaborates closely with academic leaders from institutions such as the University of Cambridge and Cancer Research UK. There are no disclosed late-stage clinical results or approved products yet.
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic platform (proprietary precision oncology platform)AI-driven drug discovery platformMachine learning-based diagnostics
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on Tailor Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tailor Bio.